SOURCE: BioServe

March 28, 2007 09:00 ET

BioServe Receives ISO 9001 and CLIA Certifications

Widely Recognized Certifications Further Validate BioServe's Operational and Organizational Excellence

LAUREL, MD -- (MARKET WIRE) -- March 28, 2007 -- BioServe, the leader for rapid, economical processing and analyses of genomic content from biological samples, today announced it has received two milestone certifications -- ISO (International Organization for Standardization) 9001 and CLIA (Clinical Laboratory Improvement Act).

ISO is a worldwide federation of national standards adopted by 154 countries and has become an international reference for quality management requirements in business-to-business dealings. BioServe chose to have its site in India certified by ISO, a process that includes comprehensive and rigorous auditing, to actively illustrate its commitment to provide only the best quality products and service for its customers.

CLIA is a regulatory program that sets standards for operating a clinical laboratory in the USA, and it mandates that any laboratory conducting testing on human specimens must be certified to operate in accordance with the federal government's Clinical Laboratory Improvement Act.

"These certifications further validate BioServe's operational and organizational excellence," said Rama Modali, President of BioServe. "For the past 15 years BioServe has delivered superior services for extracting and analyzing genomic content. BioServe's customers, whether a bio-pharmaceutical company or a public research institution, have come to expect the highest quality work with reduced project cycle times, along with the ability to overcome challenging business and scientific hurdles. With the ISO and CLIA certifications, our customers can be confident of our continued commitment to providing the highest quality services, products and technology."

About BioServe

BioServe delivers a complete 'biomaterial to validated data' genomics solution. BioServe's rapid, economical processing and analyses of genomic content from biological samples helps researchers worldwide to gain the pre-clinical genomic results required to achieve breakthroughs in research, drug discovery and molecular diagnostics. BioServe's technology, products and services form the foundation for optimal pre-clinical workflows spanning innovative methodologies for processing nucleic acids, DNA synthesis, high throughput sequencing and genotyping, genome wide-scans and gene expression analyses. BioServe's customers include leading pharmaceutical and biotechnology companies, and government and academic research institutions. BioServe has headquarters in Laurel, MD and Hyderabad, India. For more information please visit www.bioserve.com or call 301-470-3362.

Contact Information

  • Contacts:
    Vipin Adhlakha
    BioServe
    301-470-3362
    Email Contact

    Constantine Theodoropulos
    Boston Communications
    617-619-9801
    Email Contact